Dean Mitchell – Executive Chairman of the Board
Dean Mitchell is the Executive Chairman of the Board of Covis Pharma Holdings – the parent company of Covis Pharma. He has built successful pharmaceutical businesses in both the public and private sector and is an expert at strategic planning and product development.
Prior to joining Covis Holdings, Dean served as President and CEO of Lux Biosciences and held senior positions at Bristol-Myers Squibb as well as GlaxoSmithKline.
Dean Mitchell holds an MBA degree from City University Business School, London, England, and a B.S. degree in Applied Biology from Coventry University, UK.
Michael Porter – Chief Executive Officer
Michael Porter is the CEO of Covis Pharma. Previously he was COO of Covis Pharma Sarl, where he was responsible for the partial monetization of the business for $1.2 billion. He has over 20 years of private equity experience. Prior to Covis, Michael was with Cerberus Capital Management where he was a Senior Operating Executive.
He was previously with another large distressed private equity fund and began his career at AlixPartners in their Turnaround and Performance Improvement Group.
Michael received his MBA from Columbia Business School with a concentration in Finance via the accelerated program. In addition, he studied International Business at Senshu University in Kawasaki, Japan. Michael speaks English, Spanish, Portuguese, French, Japanese, and Russian.
Aziza Johnson – VP, Regulatory Affairs
Aziza Johnson is the VP of Regulatory Affairs for Covis Pharma. She has over 18 years of progressive global regulatory experience in the pharmaceutical industry leading project teams from early development through to commercial launch. Aziza has been active in all her roles and has led projects through start up, launch, survival, and growth.
Prior to Covis, Aziza worked in a variety of environments (small, medium, and large pharmaceutical organizations) with increasing roles and responsibility and in more recent years, including management roles. In addition, Aziza worked at the Medicines and Healthcare Regulatory Agency as a pharmaceutical assessor, where she gained useful insight into the operations of the UK Regulatory agency. Aziza attended the University of London School of Pharmacy and the University of Leicester where she received her B.Pharm. (Hons.) and Masters in Law respectively.
Fabio Fazio – VP, Head of Quality Assurance and Qualified Person
Fabio Fazio is the VP of Quality Assurance at Covis Pharma. He ensures compliance of pharmaceutical production to good manufacturing practice and to Marketing Authorizations. Fabio is responsible for the implementation of the quality systems which include the management of regulatory inspections, supplier oversight and audits, technology transfers, QP release of medicinal products to market, and adherence to good distribution practice.
Prior to Covis, Fabio worked at Biogen Idec as Qualified Person and in other technical CMC roles. Previous experiences encompass Process Development at GlaxoSmithKline in support of early stage clinical trials and basic research of novel therapeutic agents at the Scripps Research Institute in La Jolla, CA.
Fabio graduated from the Faculty of Pharmacy at the University of Siena, Italy, and received his Ph.D. in Chemistry from the University of Wuppertal, Germany.
Oliver Krug – VP, Operations
Oliver Krug is the VP of Operations at Covis Pharma. With over 18 years of experience in pharmaceutical and chemical supply chain, he is responsible for the overall end-to-end supply chain management of the Covis product portfolio, including managing supply performance of contract manufacturers, third party logistics providers and API suppliers.
Prior to Covis, Oliver worked at Merck & Co. Inc. (MSD) in various regional Supply Chain roles of increasing seniority in both the Netherlands and Switzerland. Oliver has extensive experience with the end-to-end supply chain planning of complex and highly international product flows, and is well-versed in a range of pharmaceutical technologies.
Oliver holds an MSc degree from the University of Wales (Cardiff) and has APICS CSCP certification. He speaks fluent English, German and Dutch.
Joan Fuste – Director of Finance
Joan Fuste is the Director of Finance at Covis Pharma. He has over 15 years of international experience in Finance, Controlling and Business Strategy with Fortune 500 organizations in the Healthcare and FMCG industries.
Prior to Covis, Joan worked in several Finance positions of increased responsibility for companies such as Johnson & Johnson and Abbott Laboratories. He is internationally experienced in business integration and change in different cultural environments, working in countries like Germany, Belgium, Spain, Switzerland and the UK.
Joan graduated with a degree in Business Administration at the University of Barcelona and holds a Postgraduate degree in Finance from the UPF University. He also studied International Business at San Diego State University in California. Joan speaks English, Spanish, Catalan, French and German.